e-learning
resources
European Respiratory Review
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
Gossez Morgane, Levesque Marianne, Khouatra Chahéra, Cottin Vincent, Garnier Lorna, Fabien Nicole
Source:
Eur Respir Rev 2015; 24: 370-372
Journal Issue:
June
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gossez Morgane, Levesque Marianne, Khouatra Chahéra, Cottin Vincent, Garnier Lorna, Fabien Nicole. Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody. Eur Respir Rev 2015; 24: 370-372
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Interstitial lung diseases associated with amyopathic dermatomyositis
Source: Eur Respir J 2006; 28: 1005-1012
Year: 2006
The prevalence and subtypes of interstitial lung disease in polymyositis and dermatomyositis patients
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Anti-parietal cell autoimmunity in IPF patients
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Rituximab therapy for interstitial lung disease in patients with antisynthetase syndrome
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Interstitial lung disease (ILD) in association with polymyositis-dermatomyositis (PM/DM) with predominant lymphocytic alveolitis and anti-Jo-1-antibodies
Source: Eur Respir J 2002; 20: Suppl. 38, 586s
Year: 2002
Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Interstitial lung disease associated with polymyositis-dermatomyositis
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005
Clinical features of interstitial lung disease in polymyositis and dermatomyositis
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis
Source: Eur Respir J 2003; 22: 245-250
Year: 2003
Autoantibodies in interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Long-term outcome of 53 patients with anti-Jo-1 antibody-positive interstitial lung disease
Source: International Congress 2017 – Rare diseases
Year: 2017
Myositis-associated interstitial pneumonia (MaIP): Autoantibody associations in patients presenting to pulmonologists and rheumatologists
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept